Malaria vaccine soon on the market

In 2009 malaria vaccine enters in clinical phase III after a long term clinical study performed in Tanzania. Thousands of children die everyday in Sub-Saharan Africa because of malaria and men and women spend a lot of time and money to care this disease. The vaccine should be a great promise and hope for these populations.
The clinical trial of malaria vaccine involves 16000 children aged from two years to eleven in seven different African countries. The vaccine is a fusion of a protein from malaria parasite and surface antigen form hepatitis B virus. The main goal is block symptoms of malaria (fever, weakness, death) and maintain protection for several years. If everything goes well, vaccine will be submitted for regulatory approval by 2011 and it will be on the market by 2012. The Global Fund to Fight AIDS, Tuberculosis and Malaria and the Global Alliance for Vaccine and Immunizations ensure vaccine to reach the market.
This clinical trial open new opportunities to care malaria. This terrible disease kills a lot of children in poor countries every year also because anti-malaria drugs are very expensive and government cannot pay them. We have to keep our finger crossed for this clinical trial!